Creo Medical Group Statistics

Total Valuation

Creo Medical Group has a market cap or net worth of GBP 77.41 million. The enterprise value is 81.81 million.

Market Cap	77.41M
Enterprise Value	81.81M

Important Dates

The last earnings date was Friday, December 13, 2024.

Earnings Date	Dec 13, 2024
Ex-Dividend Date	n/a

Share Statistics

Creo Medical Group has 402.15 million shares outstanding. The number of shares has increased by 61.03% in one year.

Current Share Class	n/a
Shares Outstanding	402.15M
Shares Change (YoY)	+61.03%
Shares Change (QoQ)	+0.60%
Owned by Insiders (%)	5.13%
Owned by Institutions (%)	65.50%
Float	361.27M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	2.29
PB Ratio	1.47
P/TBV Ratio	3.49
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-3.65
EV / Sales	2.70
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-3.82

Financial Position

The company has a current ratio of 3.24, with a Debt / Equity ratio of 0.30.

Current Ratio	3.24
Quick Ratio	2.38
Debt / Equity	0.30
Debt / EBITDA	n/a
Debt / FCF	-0.66
Interest Coverage	-42.33

Financial Efficiency

Return on equity (ROE) is -38.49% and return on invested capital (ROIC) is -22.71%.

Return on Equity (ROE)	-38.49%
Return on Assets (ROA)	-20.09%
Return on Capital (ROIC)	-22.71%
Revenue Per Employee	108,993
Profits Per Employee	-80,576
Employee Count	287
Asset Turnover	0.38
Inventory Turnover	1.85

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -55.10% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-55.10%
50-Day Moving Average	17.75
200-Day Moving Average	28.65
Relative Strength Index (RSI)	65.14
Average Volume (20 Days)	1,063,790

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Creo Medical Group had revenue of GBP 30.30 million and -22.40 million in losses. Loss per share was -0.06.

Revenue	30.30M
Gross Profit	15.00M
Operating Income	-25.40M
Pretax Income	-25.10M
Net Income	-22.40M
EBITDA	-22.70M
EBIT	-25.40M
Loss Per Share	-0.06

Full Income Statement

Balance Sheet

The company has 9.80 million in cash and 14.20 million in debt, giving a net cash position of -4.40 million or -0.01 per share.

Cash & Cash Equivalents	9.80M
Total Debt	14.20M
Net Cash	-4.40M
Net Cash Per Share	-0.01
Equity (Book Value)	47.40M
Book Value Per Share	0.13
Working Capital	22.20M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -20.10 million and capital expenditures -1.30 million, giving a free cash flow of -21.40 million.

Operating Cash Flow	-20.10M
Capital Expenditures	-1.30M
Free Cash Flow	-21.40M
FCF Per Share	-0.05

Full Cash Flow Statement

Margins

Gross margin is 49.50%, with operating and profit margins of -83.83% and -73.93%.

Gross Margin	49.50%
Operating Margin	-83.83%
Pretax Margin	-82.84%
Profit Margin	-73.93%
EBITDA Margin	-74.92%
EBIT Margin	-83.83%
FCF Margin	n/a

Dividends & Yields

Creo Medical Group does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-61.03%
Shareholder Yield	-61.03%
Earnings Yield	n/a
FCF Yield	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Creo Medical Group has an Altman Z-Score of -0.19. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-0.19
Piotroski F-Score	n/a